10-Q: Quarterly report
Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
EFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined With Pembrolizumab in Non-Small Cell Lung Cancer
Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
EFFECTOR Therapeutics (NASDAQ:EFTRW) Shares Down 13.1%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) traded down 13.1% on Wednesday . The company traded as low as $0.10 and last traded at $0.12. 898 shares traded hands during trading, a decline
EFFECTOR Therapeutics (NASDAQ:EFTRW) Trading Up 21.4%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) shot up 21.4% on Wednesday . The stock traded as high as $0.17 and last traded at $0.16. 1,403 shares changed hands during mid-day trading, a de
EFFECTOR Therapeutics (NASDAQ:EFTRW) Trading Down 15.7%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) traded down 15.7% during mid-day trading on Thursday . The stock traded as low as $0.10 and last traded at $0.16. 3,151 shares were traded dur
Short Interest in EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Decreases By 23.9%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 26,800 shares
EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 share
Gold futures closed down 0.8% on Tuesday to hit the lowest closing price in 7 weeks
In the early morning of the 29th, Beijing time, due to the steady rise in US Treasury yields and the strengthening of the US dollar, gold futures hit their lowest closing price in seven weeks on Tuesday. Gold futures for December delivery on the New York Mercantile Exchange fell $14.50, or 0.8%, to close at $1737.50 an ounce. Based on the most active contract price, Tuesday's gold futures hit the lowest closing price since August 10. Treasury bond yields and the US dollar exchange rate rose at the same time, putting pressure on the price of gold. US benchmark 10-year Treasury yields rose and topped 1.5% on Tuesday, while the US dollar index (DXY) rose 0.4%. country
No Data